Holen Sie sich die Stockscreener-App
2.25
4.66%
-0.11
Handel nachbörslich:
2.32
0.07
+3.11%
Schlusskurs vom Vortag:
$2.36
Offen:
$2.38
24-Stunden-Volumen:
810.21K
Relative Volume:
1.44
Marktkapitalisierung:
$126.62M
Einnahmen:
$76.19M
Nettoeinkommen (Verlust:
$-1.61M
KGV:
225.00
EPS:
0.01
Netto-Cashflow:
$28.98M
1W Leistung:
+9.76%
1M Leistung:
+15.98%
6M Leistung:
+289.61%
1J Leistung:
+81.45%
1-Tages-Spanne:
$2.25
$2.41
1-Wochen-Bereich:
$2.02
$2.42
52-Wochen-Spanne:
$0.5052
$3.22
Spero Therapeutics Inc Stock (SPRO) Company Profile
Firmenname
Spero Therapeutics Inc
Sektor
Branche
Telefon
857-242-1600
Adresse
675 MASSACHUSETTS AVENUE, CAMBRIDGE, MA
Vergleichen Sie SPRO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SPRO
Spero Therapeutics Inc
|
2.25 | 132.81M | 76.19M | -1.61M | 28.98M | 0.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Spero Therapeutics Inc Stock (SPRO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-20 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-09-23 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2021-10-01 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2021-01-22 | Bestätigt | H.C. Wainwright | Buy |
| 2020-12-16 | Eingeleitet | Berenberg | Buy |
| 2020-09-29 | Eingeleitet | Evercore ISI | Outperform |
| 2019-11-05 | Bestätigt | H.C. Wainwright | Buy |
| 2019-09-09 | Eingeleitet | Janney | Buy |
| 2018-02-09 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-11-27 | Eingeleitet | BofA/Merrill | Neutral |
| 2017-11-27 | Eingeleitet | Oppenheimer | Outperform |
| 2017-11-27 | Eingeleitet | Stifel | Buy |
Alle ansehen
Spero Therapeutics Inc Aktie (SPRO) Neueste Nachrichten
Key resistance and support levels for Spero Therapeutics Inc.Portfolio Gains Report & Stock Timing and Entry Methods - newser.com
Sector ETF performance correlation with Spero Therapeutics Inc.July 2025 Reactions & Consistent Income Trade Recommendations - newser.com
Best Momentum Stock to Buy for October 10th - Yahoo
Spero Therapeutics' (SPRO) Sell (D-) Rating Reaffirmed at Weiss Ratings - MarketBeat
What analysts say about Spero Therapeutics Inc stockSell Signals and Alerts & Breakthrough Investment Results - earlytimes.in
Spero Therapeutics (NASDAQ:SPRO) Rating Increased to Strong-Buy at Zacks Research - MarketBeat
October 2025's Promising Penny Stocks To Consider - simplywall.st
Key metrics from Spero Therapeutics Inc.’s quarterly dataWall Street Watch & Low Risk High Reward Ideas - newser.com
How strong is Spero Therapeutics Inc. stock revenue growth2025 Biggest Moves & AI Driven Stock Reports - newser.com
Heatmap analysis for Spero Therapeutics Inc. and competitors2025 Institutional Moves & Weekly Breakout Watchlists - newser.com
Is Spero Therapeutics Inc. (2HA) stock positioned for digital growth eraTrade Signal Summary & Free Safe Capital Growth Stock Tips - newser.com
Is Spero Therapeutics Inc. (2HA) stock safe for risk averse investors2025 Short Interest & Risk Adjusted Swing Trade Ideas - newser.com
Will Spero Therapeutics Inc. see short term momentumTrade Analysis Report & Daily Volume Surge Signals - newser.com
Spero Therapeutics CEO sells shares worth $121,159 - MSN
Spero Therapeutics Inc. stock trend forecastJuly 2025 Levels & Real-Time Chart Breakout Alerts - newser.com
Is Spero Therapeutics Inc a good long term investmentProtective Put Strategies & Amplify Gains With Picks - earlytimes.in
Is Leap Therapeutics Inc. (5MC) stock cheap vs fundamentalsDip Buying & Verified Momentum Stock Watchlist - newser.com
Finanzdaten der Spero Therapeutics Inc-Aktie (SPRO)
Umsatz
Nettogewinn
Free Cashflow
ENV
Spero Therapeutics Inc-Aktie (SPRO) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Keutzer Timothy | Chief Operating Officer |
Aug 28 '25 |
Sale |
1.97 |
1,695 |
3,339 |
739,744 |
| Keutzer Timothy | Chief Operating Officer |
Feb 05 '25 |
Sale |
0.78 |
56,537 |
44,099 |
741,439 |
| Rajavelu Esther | CFO & CBO |
Feb 05 '25 |
Sale |
0.78 |
20,689 |
16,137 |
724,720 |
| Shukla Sath | CEO & President |
Feb 05 '25 |
Sale |
0.78 |
155,333 |
121,160 |
1,736,883 |
| Mahadevia Ankit | Director |
Feb 05 '25 |
Sale |
0.78 |
69,219 |
53,991 |
689,866 |
| Rajavelu Esther | CFO & CBO |
Nov 07 '24 |
Sale |
1.31 |
23,351 |
30,590 |
396,515 |
| Rajavelu Esther | CFO & CBO |
Nov 08 '24 |
Sale |
1.30 |
17,245 |
22,418 |
379,270 |
5.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):